Hanmi Pharmaceutical
OverviewSuggest Edit
Hanmi Pharmaceutical is a company focused on the development and commercialization of pharmaceutical products. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases.
| Type | Public | |
| Founded | 1973 | |
| Website | hanmipharm.com | |
| Employee Ratings | More |
Hanmi Pharmaceutical Financials and Metrics
Hanmi Pharmaceutical Revenue
Market capitalization (16-Jun-2021) | 3.9t |
Closing stock price (16-Jun-2021) | 327.5k |
Hanmi Pharmaceutical's current market capitalization is ₩3.9 t.
Hanmi Pharmaceutical Cybersecurity Score
Hanmi Pharmaceutical Environment, Social & Governance (ESG) Ratings
Hanmi Pharmaceutical Online and Social Media Presence
Hanmi Pharmaceutical's Trends
Hanmi Pharmaceutical Frequently Asked Questions
When was Hanmi Pharmaceutical founded?
Hanmi Pharmaceutical was founded in 1973.
How many employees does Hanmi Pharmaceutical have?
Hanmi Pharmaceutical has 2,444 employees.
Who are Hanmi Pharmaceutical competitors?
Competitors of Hanmi Pharmaceutical include Alembic Pharmaceuticals, Biocon and Cipla.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies